Applied Molecular Transport Appoints Charlene Banard to its Board of Directors
SOUTH SAN FRANCISCO, Calif., April 06, 2022 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical...
Day: April 6, 2022
OrthoPediatrics’ ApiFix® System Selected as 2022 MDEA Finalist
WARSAW, Indiana, April 06, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company exclusively focused...
Lower vaccination rates among people who use drugs could lead to serious outcomes from COVID-19
VANCOUVER, British Columbia, April 06, 2022 (GLOBE NEWSWIRE) -- As many jurisdictions in Canada begin to ease public health measures...
Sema4 Achieves HITRUST CSF Certification
HITRUST CSF Certification validates Sema4’s commitment to meeting key healthcare regulations and protecting sensitive informationSTAMFORD, Conn., April 06, 2022 (GLOBE...
Ocuphire Pharma to Present at Wet AMD & DME Drug Development Summit in Boston, MA
FARMINGTON HILLS, Mich., April 06, 2022 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused...
Avadel Pharmaceuticals Announces Publication of Positive Secondary Endpoint Data from Pivotal Phase 3 REST-ON Trial
Once-at-bedtime FT218 demonstrated clinically meaningful improvement in assessments of disrupted nighttime sleep compared to placebo in adults with narcolepsyNew data...
PepGen Announces First Participant Dosed in a Phase 1 Clinical Trial of PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy
- Initiation of Phase 1 Study Marks PepGen’s Transition to a Clinical Stage Company - - This Phase 1 Healthy...
BetterLife’s BETR-001 Demonstrates BETR-001 Anti-depressant Activity in Preclinical Models of Depression
VANCOUVER, British Columbia, April 06, 2022 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF...
Collegium Appoints Neil McFarlane to its Board of Directors
STOUGHTON, Mass., April 06, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today...
New Study from Duke Heart Demonstrates the Unique Accuracy and Utility of Daxor’s Blood Volume Diagnostic (BVA-100®) for Improving Worsening Heart Failure
Study Presented at the 71st Annual American College of Cardiology Meeting Oak Ridge, TN, April 06, 2022 (GLOBE NEWSWIRE) --...
Morphic Therapeutic Expands Leadership with Key Appointments in Clinical and Corporate Development
Dr. Brihad Abhyankar named Vice President of Clinical Development, deeply experienced GI drug development leaderAaron Pelta promoted to Senior Vice...
Evaxion Biotech Hosting Key Opinion Leader Webinar on Metastatic Melanoma and Personalized Cancer Immunotherapies
Tuesday, April 12th @ 12:30 pm ETCOPENHAGEN, Denmark, April 06, 2022 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”...
Context Therapeutics® to Participate in Two April 2022 Investor Conferences
PHILADELPHIA, April 06, 2022 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company...
TG Therapeutics Announces Oral Presentation of Data from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis at the American Academy of Neurology Annual Meeting
NEW YORK, April 06, 2022 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that data from the ULTIMATE I &...
CloudMD Announces CEO Succession
Dr. Essam Hamza stepping down as CEO and President, Karen Adams appointed as Interim CEOVANCOUVER, British Columbia, April 06, 2022...
Inozyme Pharma to Present at the 21st Annual Needham Virtual Healthcare Conference
BOSTON, April 06, 2022 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage biopharmaceutical company developing novel therapeutics for...
Government inaction on workplace protections undermining pandemic recovery and abandoning workers in sixth wave, according to health experts
TORONTO, April 06, 2022 (GLOBE NEWSWIRE) -- As Ontario faces a sixth wave of COVID infections and restrictions are being...
OpGen’s subsidiary Ares Genetics provides update on collaboration agreement to drive cutting-edge digital solutions in global fight against antimicrobial resistance (AMR)
Extended existing master services agreement with Sandoz, to develop digital platform for development and life cycle management of antibiotics, to...
Cognition Therapeutics Announces Participation in 21st Annual Needham Virtual Healthcare Conference
PURCHASE, N.Y., April 06, 2022 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical stage neuroscience company developing drugs...
CorVel Releases the New Integrated Claims Risk Score for Workers’ Compensation Claims, Leveraging Artificial Intelligence and Predictive Analytics
The new functionality in CareMC Edge® assesses multiple factors to determine a claim risk score, helping claims professionals proactively address potential...
